期刊文献+

抑制幽门螺杆菌乳酸菌的筛选及抑菌物质的特性研究

Screening of Lactic Acid Bacteria Inhibiting Helicobacter Pylori and Study on the Characteristics of Antibacterial Substances
下载PDF
导出
摘要 为获得能够抑制幽门螺杆菌的乳酸菌,文章从泡菜中筛选得到10株乳酸菌,并运用牛津杯法分别对这10株乳酸菌开展抑制幽门螺杆菌的试验。其中,有3株乳酸菌具有抑菌活性,分别为PW-2、PW-5和PW-7,且菌株PW-2的抑菌直径最大。通过观察菌株形态特征,并与16S rDNA基因序列进行比对分析,确定该菌株为植物乳杆菌。对该菌中的抑菌活性物质进行研究后发现,排除乳酸和H2O_(2)后,其仍具有抑菌活性。同时,蛋白酶敏感试验表明,该菌株发酵液中的抑菌物质是蛋白质或多肽。此外,菌株PW-2中的抑菌物质在酸性条件下的抑菌活性较强,且具有一定的温度稳定性。 In order to obtain lactic acid bacteria that can inhibit Helicobacter pylori,this study has screened 10 strains of lactic acid bacteria from pickled vegetables and conducted experiments on inhibition of Helicobacter pylori using the Oxford Cup method on these 10 strains.The results show that three of these 10 strains,PW-2,PW-5,and PW-7,have antibacterial activity against Helicobacter pylori.The PW-2 strain has the largest antibacterial diameter.This strain has been identified as Lactobacillus plantarum through morphological characteristics and 16S rDNA gene sequence alignment analysis.Further research has been conducted on the antibacterial active substances of this strain,and after excluding lactic acid and H2O_(2),it still shows antibacterial activity.Then,the subsequent protease sensitivity test shows that the antibacterial substances in the fermentation broth of the strain are proteins or peptides.In addition,the antibacterial substances of strain PW-2 exhibit strong antibacterial activity under acidic conditions and have the certain temperature stability.
作者 武航婕 武秀秀 屠晨坤 WU Hangjie;WU Xiuxiu;TU Chenkun(Kangda College of Nanjing Medical University,Lianyungang 222000,China)
出处 《工业微生物》 CAS 2024年第3期22-24,共3页 Industrial Microbiology
基金 南京医科大学康达学院2021年度科研发展基金课题(KD2021KYJJZD023) 南京医科大学康达学院第一期“科研人才培养计划”(KD2021KYRC021) 南京医科大学康达学院第一期“科研创新团队项目”(KD2022KYCXTD003)。
关键词 幽门螺杆菌 乳酸菌 抑菌活性 Helicobacter pylori Lactic acid bacteria bacteriostatic activity
  • 相关文献

参考文献3

二级参考文献42

  • 1秦卫,郁慕鲁.双歧三联活菌散剂加法莫替丁根治幽门螺杆菌感染疗效观察[J].现代医药卫生,2006,22(1):20-21. 被引量:2
  • 2曹艳菊,张豫生,屈昌民,袁群.幽门螺杆菌治疗中抗生素相关性腹泻的预防[J].中华医院感染学杂志,2006,16(5):559-560. 被引量:19
  • 3赵青,张镁硒.幽门螺杆菌相关毒素抗体阳性儿童的微生态治疗[J].中国现代医生,2007,45(07S):22-23. 被引量:6
  • 4JAGUSZTYN-KRYNICKA E K, GODLEWSKA R. New approaches for Helicobacter vaccine developmcnt--difficulties and progress [ J ]. Pol J Microbiol,2008,57 ( 1 ) : 3 -9.
  • 5FRANCESCHI F, GASBAORINI A. Helicobacter pylori and extragastric diseasdes [ J ]. Best Pract Res Clin Gastroenteml, 2007, 21 ( 2 ) : 325-334.
  • 6SOUGIOULTZIS S,LEE C K,ALSAHLI M,et al. Safety and efficacy of E. coli enterotoxln adjuvant for urease-based rectal immunization against Helicobacter pylor/[ J]. Vaccine ,2002,21 ( 3-4 ) : 194-201.
  • 7DAS J C, PAUL N. Epidemiology and pathophysiology of Helicobacter pylori infection in children [ J ]. Indian J Pediatr, 2007, 74 ( 3 ) : 287-290.
  • 8] SCHREZENMEIR J, de VRESE M. Probiotics, prebiotics, and synbioties-approaehing a definition[J]. Am J Clin Nutr,2001,73 (2 Suppl) :361S-364S.
  • 9REID G, JASS J, SEBULSKY M T, et al. Potential uses of probiotics in clinical practice[ J]. Clin Microbiol Rev ,2003 ; 16 (4) :658-672.
  • 10SHEU B S, CHENG H C, KAO A W,et al. Pretreatment with Lactobacillus - and yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy [ J]. Am J Clin Nutr,2006,83 (4) : 864-869.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部